Imperva Inc (NASDAQ:IMPV) was the recipient of unusually large options trading activity on Monday. Stock traders bought 1,059 call options on the company. This is an increase of approximately 1,758% compared to the typical volume of 57 call options.
A number of institutional investors and hedge funds have recently bought and sold shares of IMPV. Carillon Tower Advisers Inc. bought a new stake in Imperva in the 4th quarter valued at $36,802,000. Alyeska Investment Group L.P. lifted its position in Imperva by 89.3% in the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after acquiring an additional 428,163 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its position in Imperva by 171.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 475,000 shares of the software maker’s stock valued at $20,702,000 after acquiring an additional 300,000 shares in the last quarter. Renaissance Technologies LLC lifted its position in Imperva by 55.2% in the 4th quarter. Renaissance Technologies LLC now owns 798,100 shares of the software maker’s stock valued at $31,685,000 after acquiring an additional 283,700 shares in the last quarter. Finally, BlackRock Inc. lifted its position in Imperva by 11.3% in the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after acquiring an additional 215,170 shares in the last quarter. 93.61% of the stock is currently owned by institutional investors and hedge funds.
A number of research firms have commented on IMPV. Piper Jaffray Companies raised shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 target price for the company in a report on Friday, February 9th. JPMorgan Chase & Co. lowered shares of Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 price target for the company. in a report on Tuesday, December 12th. Zacks Investment Research lowered shares of Imperva from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Imperial Capital boosted their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, February 9th. Finally, KeyCorp reissued a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Three analysts have rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $52.93.
Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the consensus estimate of $0.27 by $0.13. The business had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. The firm’s revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 EPS. research analysts expect that Imperva will post -0.82 earnings per share for the current fiscal year.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.